• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vor Biopharma Inc (NQ: VOR )

    0.6713 +0.0103 (+1.56%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 290,095
    Open 0.6831
    Bid (Size) 0.6650 (45)
    Ask (Size) 0.6800 (110)
    Prev. Close 0.6610
    Today's Range 0.6620 - 0.6880
    52wk Range 0.6300 - 3.140
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
    From Vor Biopharma
    Via GlobeNewswire

    Performance

    YTD
    -69.90%
    -69.90%
    1 Month
    -18.63%
    -18.63%
    3 Month
    -25.91%
    -25.91%
    6 Month
    -69.35%
    -69.35%
    1 Year
    -65.57%
    -65.57%

    More News

    Read More
    Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
    Via Benzinga
    Exposures Product Safety
    Vor Biopharma: Q4 Earnings Insights
    Via Benzinga
    Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio to Participate in Upcoming Investor Conferences
    From Vor Biopharma
    Via GlobeNewswire
    VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024
    Via InvestorPlace
    Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024
    Via InvestorPlace
    Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio to Participate in Upcoming Investor Conferences
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
    From Vor Biopharma
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Vor Bio to Participate in Upcoming Investor Conferences
    From Vor Biopharma
    Via GlobeNewswire
    The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
    Via InvestorPlace
    VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023
    Via InvestorPlace
    Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Vor Biopharma
    Via GlobeNewswire
    Vor Bio to Participate in Upcoming Investor Conferences
    From Vor Biopharma
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.